Ana Maria Gonzalez-Angulo0000-0002-9816-2707
Ana Maria Gonzalez-Angulo holds the M.D., M.S., and Ph.D. degrees and serves as an Associate Professor of medicine and Chief, Section of Clinical Research and Drug Development, at the Departments of Breast Medical Oncology and Systems Biology, The University of Texas, Austin, TX, USA, and also at MD Anderson Cancer Center, Houston, TX, USA. Gonzalez-Angulo attended Medical School at the Universidad del Cauca, Cauca, Colombia, and moved to USA to continue her training. She completed her residency in internal medicine at the Mount Sinai Medical Center in Miami, FL, USA, and a fellowship in medical oncology at the Ochsner Clinic Foundation in New Orleans, LA, USA. She then went to MD Anderson Cancer Center, The University of Texas, to specialize in breast cancer as she was selected as the Susan G. Komen Breast Cancer Fellow. She stayed at MD Anderson Faculty and worked exclusively with breast cancer patients and in breast cancer research. She leads the Clinical Research and Drug Development Section of the department. Gonzalez-Angulo is interested in aggressive types of breast cancer including triple receptor-negative disease. Her research focuses on mechanisms of resistance to standard breast cancer therapies and on the development of markers to predict response to treatments using functional proteomics.
Biography Updated on 28 March 2014